Compare UMAC & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UMAC | ETON |
|---|---|---|
| Founded | 2019 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 642.2M | 683.7M |
| IPO Year | 2023 | 2018 |
| Metric | UMAC | ETON |
|---|---|---|
| Price | $13.92 | $26.82 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $20.00 | ★ $39.33 |
| AVG Volume (30 Days) | ★ 4.8M | 468.4K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 80.73 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $11,199,217.00 | ★ $79,950,000.00 |
| Revenue This Year | $115.39 | $40.90 |
| Revenue Next Year | $101.44 | $47.23 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 101.23 | ★ 104.94 |
| 52 Week Low | $4.67 | $13.09 |
| 52 Week High | $23.38 | $27.19 |
| Indicator | UMAC | ETON |
|---|---|---|
| Relative Strength Index (RSI) | 48.21 | 72.12 |
| Support Level | $13.66 | $16.38 |
| Resistance Level | $16.52 | N/A |
| Average True Range (ATR) | 1.43 | 1.28 |
| MACD | 0.00 | 0.08 |
| Stochastic Oscillator | 67.48 | 90.65 |
Unusual Machines Inc is engaged in manufactures and sells drone components and drones across a diversified brand portfolio through business-to-business (B2B) sales and a curated retail channel.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.